NEW YORK (GenomeWeb News) – Princeton University researchers will use around $1.8 million in American Recovery and Reinvestment Act funding from the National Institutes of Health and the National Science Foundation to support 'omics-focused studies of antibiotic resistance, cancer, and biological development.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.